Market
Insights:
In vivo imaging facilitates the early
detection of biological abnormalities in a living being and helps in curbing
its ill effects which have catalyzed the
demand in the global in vivo imaging market. Market Research Future (MRFR) has
unfolded in its latest report that the global in vivo imaging market trends will witness demand escalation
leading to maximization of profits by 2023.
The potential of in vivo imaging industry
has been proven in treating lethal diseases such as cancer, tumor, etc. which
has led to its rapid adoption in the healthcare
sector. According to a report published by the World
Health Organization (WHO) in 2017, one
out of every six deaths had been caused
by cancer in 2015. National Cancer Institute, the U.S., reveals that about 1.6
million new cases of cancer were diagnosed
in 2010. It also highlighted that the healthcare expenditure for cancer
treatment would reach approximately USD
156 Bn by 2020 from USD 125 Bn in 2010. The rising burden of cancer has
generated the demand for integrating in vivo imaging solutions into cancer diagnosis for effective
treatment.
The growing inclination towards preventive
healthcare diagnosis is the key driver of the market expansion. The rising
incidences of diseases have inflicted a
fear among the population which when coupled with multiplied disposable income
has fueled the need for frequent checkups, thereby, amplifying the market size
of in vivo imaging. Other factors favoring the increasing revenue creation from
the market are increased healthcare expenditure, developments in the healthcare sector, research & development
activities, etc.
However, the factors prevailing in the
market that will hold the market growth during the review period include low
healthcare expenditure in developing economies, lack of awareness, and uneven
technological penetration in the healthcare
sector, among others.
Market
Segmentation:
By applications, the global in vivo imaging
market has been segmented into nuclear
imaging, optical imaging, and others.
By techniques, the in vivo imaging market is segmented into radioisotopes based,
biomarkers based, luminescent proteins-based technique,
and others.
By end users, the global
in vivo imaging market has been segmented into hospitals & clinics, imaging
centers, research organizations, and others.
Regional
Analysis:
By region, the global in vivo imaging market insight has been segmented into North America, Europe, Asia, and Middle East
& Africa. North America has witnessed millions of deaths in the last decade
due to cancer which has necessitated the adoption of in vivo imaging market in
the region. Its penchant for latest technology has catalyzed the developments
in the healthcare sector which is fueling
the market for in vivo imaging. Europe
region is also burdened by the rising
incidences of cancer which is the key
factor complementing the market expansion. Furthermore, the increasing healthcare expenditure and rising awareness about fatal diseases will
catapult the growth rate of the market.
Asia market will
grow at a steady CAGR throughout the assessment period. The growth in this region can be attributed to the
initiatives undertaken by governments and established corporate houses for
revenue creation from medical tourism. Other factors responsible for the
catalyzed market expansion of the region are
increased disposable income, a bullish
trend witnessed in the healthcare sector,
increasing count of patients, etc.
Competitive
Dashboard:
The cohesive growth strategies employed by
the key players depict the robust competition in the market responsible for the
growth and expansion. The top-notch players profiled by MRFR in its report include
Bruker, MILabs B.V., FUJIFILM VisualSonics Inc., Mediso Ltd., LI-COR, Inc.,
Aspect Imaging., TRIFOIL IMAGING, MR
Solutions, Biospace Lab S.A., and, New England Biolabs among others. The
tactical gambits of these players for strengthening market foothold and gaining
prominence include clinical trials, increased investments, technological
advancements, product diversification, business expansion, etc.
Industry
Developments:
In March 2018, Luxendo, a Bruker company,
announced the extension of the InVi SPIM microscope to include full incubation
capabilities, detection optics, and, flexible
illumination using its proprietary single-plane illumination microscopy (SPIM)
technology. The technology creates an optimized platform for ‘pure life imaging’.
About
Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment